000			01600cam a22004217a 4500
001			16722104
003			OSt
005			20150408114018.0
008			110405m20109999enka b 001 0 eng d
010			_a 2011286414
015			_aGBB034225 _2bnb
016	7		_a015500500 _2Uk
020			_a9781849730457 (set)
020			_a1849730458 (set)
020			_a1849730636 (v. 1)
020			_a1849730644 (v. 2)
020			_a9781849730631 (v. 1)
020			_a9781849730648 (v. 2)
035			_a(OCoLC)ocn640075039
040			_aUKM _cUKM _dYDXCP _dGZQ _dDLC
042			_aukblsr _alccopycat
050	0	0	_aRC523 _b.E44 2010
082	0	4	_a616.831061 _222
245	0	0	_aEmerging drugs and targets for Alzheimer's disease / _cedited by Ana Martinez.
260			_aCambridge : _bRoyal Society of Chemistry, _cc2010.
300			_a2 v. : _bill. ; _c25 cm.
490	0		_aRSC drug discovery series, _x2041-3203 ; _vno. 2-3
504			_aIncludes bibliographical references and index.
505	0		_av. 1. Beta-amyloid, tau protein and glucose metabolism -- v. 2. Neuronal plasticity, neuronal protection and other miscellaneous strategies.
650		0	_aAlzheimer's disease _xChemotherapy. _911887
650		0	_aDrug targeting. _911888
700	1		_aMartínez, Ana, _d1961- _911889
710	2		_aRoyal Society of Chemistry (Great Britain) _910425
830		0	_aRSC drug discovery series ; _v2. _911890
830		0	_aRSC drug discovery series ; _v3. _911891
942			_2ddc _cBOOK
999			_c21835 _d256335